Otto Chemie Pvt. Ltd.

Phone : +91-22-2207 0099
Email : info@ottokemi.com, sales@ottokemi.com


Product Details

DKFZ-PSMA-617

2-[3-(1-Carboxy-5-{3-naphthalen-2-yl-2-[(4-{[2-(4,7,10-tris-carboxymethyl-1,4,7,10-tetraaza-cyclododec-1-yl)-acetylamino]-methyl}-cyclohexanecarbonyl)-amino]-propionylamino}-pentyl)-ureido]-pentanedioic acid

PS 0072

puriss

C49H71N9O16.CF3COOH

38229090

5%

N/A

95%+

1042.14 (net)

Vail

DKFZ-PSMA-617 is an innovative and effective therapy for castrate-resistant metastatic prostate cancer patients.

DKFZ-PSMA-617 - a novel theranostic PSMA inhibitor for both diagnosis and endoradiotherapy of prostate cancer.

Properties

Cell biology, Cancer research

95%+

Powder

Colourless / white / off-white

1041.5


Safety Information

Safety Information for this product is unavailable at this time.


DKFZ-PSMA-617
PackingsPrice (INR)
1 mg POR
5 x 1 mg POR
25 x 1 mg POR

DisclaimerThe above particulars do not release the customer from the obligation to carry out an inspection of goods received.
For laboratory use only. Not for drug, medical, household, or any other unauthorized application.
We assume no liability for misuse or unauthorized application of the product. Please test before use.